SPOK 8-K: Maintains $0.3125 Dividend, Releases Q2 2025 Results

Q: What dividend did Spok Holdings (SPOK) announce in its July 30, 2025 8-K?

The Board declared a $0.3125 per share quarterly cash dividend.

Q: When are the record and payment dates for SPOK's latest dividend?

Record date is 19 Aug 2025 ; payment date is 9 Sep 2025 .

Q: Which financial period's results are referenced in the 8-K filing?

Results cover the second quarter ended 30 Jun 2025 .

Q: Where can investors find Spok's detailed Q2 2025 financial figures?

Detailed numbers are in the attached Exhibit 99.1 earnings press release .

Q: Is Spok Holdings classified as an emerging growth company?

No; the checkbox for emerging growth company is not selected .

[8-K] Alignment Healthcare, Inc. Reports Material Event

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

On 30 July 2025, Spok Holdings, Inc. (NASDAQ: SPOK) filed a Form 8-K reporting two routine but relevant items.

Item 2.02 鈥� Earnings release: The company furnished a press release (Exhibit 99.1) announcing financial results for the quarter ended 30 June 2025. The filing itself does not include quantitative figures; investors must refer to the attached release for specifics.
Item 8.01 鈥� Dividend declaration: The Board approved a regular quarterly cash dividend of $0.3125 per share, payable 9 September 2025 to shareholders of record on 19 August 2025, reinforcing the firm鈥檚 ongoing capital-return program.

No other material events, financial statements, or strategic actions were disclosed.

Positive

$0.3125 per-share cash dividend declared, indicating continued shareholder return policy

Negative

None.

Insights

TL;DR Routine 8-K: Q2 release attached, dividend maintained, no new strategic developments; impact neutral.

The filing is largely administrative. Management continues its regular dividend of $0.3125, implying stable cash generation but offers no fresh guidance or KPI detail within the text. Without the numerical results, investors cannot assess growth, margins, or cash flow trends directly from this document. The absence of additional initiatives, transactions, or risk disclosures suggests business as usual. Overall, the 8-K neither enhances nor detracts from the investment thesis until the attached press release is reviewed.

TL;DR Dividend continuity confirmed; otherwise minimal information鈥攕teady but unremarkable for yield investors.

For dividend-oriented holders, the maintained $0.3125 quarterly payout (鈮�5% annualized yield at recent prices) confirms Spok鈥檚 commitment to shareholder returns. The ex-date cadence remains unchanged, providing predictable income. However, without financial metrics, coverage ratio and sustainability cannot be evaluated from this filing alone. Impact is therefore neutral pending review of Exhibit 99.1.

07/30/2025 - 04:01 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 30, 2025

_______________________________

Alignment Healthcare, Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware	001-40295	46-5596242
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1100 W. Town and Country Road, Suite 1600

Orange, California 92868

(Address of Principal Executive Offices) (Zip Code)

(844) 310-2247

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	ALHC	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On July 30, 2025, Alignment Healthcare, Inc. issued a press release announcing its financial results for its second quarter ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

The information contained in this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description

99.1		Press Release dated July 30, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alignment Healthcare, Inc.


Date: July 30, 2025	By:	/s/ James M. Head
		James M. Head
		Chief Financial Officer

Source:

FAQ

What dividend did Spok Holdings (SPOK) announce in its July 30, 2025 8-K?

The Board declared a $0.3125 per share quarterly cash dividend.

When are the record and payment dates for SPOK's latest dividend?

Record date is 19 Aug 2025; payment date is 9 Sep 2025.

Which financial period's results are referenced in the 8-K filing?

Results cover the second quarter ended 30 Jun 2025.

Where can investors find Spok's detailed Q2 2025 financial figures?

Detailed numbers are in the attached Exhibit 99.1 earnings press release.

Does the 8-K disclose any major transactions or strategic changes for SPOK?

No, the filing mentions only the earnings release and routine dividend declaration.

Is Spok Holdings classified as an emerging growth company?

No; the checkbox for emerging growth company is not selected.

AG真人官方

[8-K] Alignment Healthcare, Inc. Reports Material Event

Insights

FAQ

What dividend did Spok Holdings (SPOK) announce in its July 30, 2025 8-K?

When are the record and payment dates for SPOK's latest dividend?

Which financial period's results are referenced in the 8-K filing?

Where can investors find Spok's detailed Q2 2025 financial figures?

Does the 8-K disclose any major transactions or strategic changes for SPOK?

Is Spok Holdings classified as an emerging growth company?

NASDAQ:ALHC

ALHC Rankings

ALHC Latest News

ALHC Latest SEC Filings

ALHC Stock Data

AG真人官方

Trending News

[8-K] Alignment Healthcare, Inc. Reports Material Event

Insights

Equity Research Analyst neutral

Income-Focused Portfolio Manager neutral

FAQ

What dividend did Spok Holdings (SPOK) announce in its July 30, 2025 8-K?

When are the record and payment dates for SPOK's latest dividend?

Which financial period's results are referenced in the 8-K filing?

Where can investors find Spok's detailed Q2 2025 financial figures?

Does the 8-K disclose any major transactions or strategic changes for SPOK?

Is Spok Holdings classified as an emerging growth company?

NASDAQ:ALHC

ALHC Rankings

ALHC Latest News

ALHC Latest SEC Filings

ALHC Stock Data